Kania, K., J. Kania, K. Niekurzak, M. Jędrak, M. Józefiak, and P. Sobkiewicz. “FDA Approves Omaveloxolone Based on Successful Moxie Trial Results for Friedreich’s Ataxia - Review”. Journal of Education, Health and Sport, vol. 40, no. 1, Aug. 2023, pp. 111-26, doi:10.12775/JEHS.2023.40.01.010.